Speakers

Jason Acker

Professor

University of Alberta, Canada

Taby Ahsan

Director of Development

RoosterBio Inc., USA

Julie Allickson

Director, Regenerative Medicine Clinical Center

Wake Forest Institute for Regenerative Medicine, USA

Eric Alonzo

Scientist, Cellular Analytics

Bluebird Bio

Stefano Baila

Director of Operations & Business Development

Anemocyte, Italy

Chris Baldwin

Supply Chain Director

GSK, USA

Rita Barcia

Executive Director, R&D

Sentien Biotechnologies, Inc, USA

Sarindr Bhumiratana

CSO, Co-Founder

EpiBone, USA

Wen Bo Wang

Senior Vice President, Technical Operations

Fate Therapeutics, USA

Jennifer Briggs Braswell, PhD

Chief Administrative Officer

ARMI, BioFab, USA

James Brown

VP Corporate Development

Aldevron, USA

Cullen Buie

Co-Founder

Kytopen, USA

Bruce A Bunnell

Professor

Director of the Tulane Center for Stem Cell Research & Regenerative Medicine, USA

Scott Burger

Principal

Advanced Cell & Gene Therapy, USA

Joseph Carosi

Associate Director

Novartis, USA

Veeren M Chauhan

Research Fellow

University of Nottingham, USA

Francesco Cicirello

Chairman of the PIC/S Working Group on the revision of Annex 2

and Deputy Chairman of the PIC/S Sub-Committee on the Harmonisation of GMDP / Pharmaceutical Inspection Co-operation Scheme

Jakub Cierny

Senior Quality Compliance Manager

Sotio AS, Czech Republic

Elena Costariol

EngD Researcher

UCL, UK

Robert Curry

Board Vice-Chair

ISIA, USA

Xavier de Mollerat du Jeu

Director, Product Management, Cell Biology

Thermo Fisher Scientific, USA

David Dobnik

Scientific Associate

National Institute of Biology, Slovenia

Francis Dupont

Head of Technology

Novasep, Brussels

Shannon Eaker

Cell Therapy Tech Sales Leader - Enterprise

GE Healthcare, USA

Stephen Elliman

Chief Scientific Officer

Orbsen Therapeutics, USA

Miguel Esteves

Associate Professor, Horae Gene Therapy Center

University of Massachusetts Medical School , USA

Evonne R. Fearnot

Marketing Manager

Roche CustomBiotech, USA

Adam Feinberg

Arthur Hamerschlag Career Development Professor

Carnegie Mellon University, USA

Joshua Flowers

CEO and C-Founder

Revive Centers, USA

Miguel Forte

CEO

Zelluna Immunotherapy, Norway

Sergio Fracchia

Global regCMC Director, Cell and Gene Therapy

Novartis, Switzerland

Pete Gagnon

Chief Scientific Officer

BIA Separations, Slovenia

Eileen Galvin Karr

Apheresis Site Manager

Key Biologics LLC, USA

Rene Gantier

Director Process Research & Development

Pall Biotech, USA

Guanping Gao

Professor, Microbiology & Physiological Systems, Penelope Booth Rockwell Professor in Biomedical Research, Co-Director, Li Weibo Institute for Rare Diseases Research, Director, Horae Gene Therapy Center and Vector Core, Scientific Director

UMMS-China Program Office, USA

Chris Gemmiti, Ph.D.

VP Operations

Sentien Biotechnologies Inc.

Henry George

Head, Viral Vectors and Viral Gene Therapy Bioprocessing R&D

MilliporeSigma, USA

Dan Gincel

VP University Partnerships, TEDCO Executive Director, MD Stem Cell Research Fund

Maryland Stem Cell Research Fund, USA

Peter Gingras

President & CEO

Viscus Biologics LLC, USA

Laurie Glimcher, MD

President and CEO

Dana-Farber Cancer Institute

Clive Glover

Director, Cell and Gene Therapy

Pall Biotech, United Kingdom

Shon Green

Director, Clinical Translation

Altius Institute for Biomedical Sciences, USA

Patrick Hanley

Immunotherapy GMP & Research Assistant Professor & Director

Children's National Health System, USA

John Heffernan

V.P. Commercial Manufacturing

Astellas

Derek Hei

Chief of Manufacturing and Technical Operations

BlueRock Therapeutics, USA

John Hewes

Senior Specialist

Invention Development, DHHS/NIH/NCI Technology Transfer Center, USA

Geoffrey Hodge

Chief Technical Officer

Unum Therapeutics

Spencer Hoover

Director of Process and Analytical Development

CCRM, Canada

Jeffrey Hung

Chief Commercial Officer

Vigene Biosciences, Inc., USA

Meridith Hyres

Lead Supply Manager of Clinical Drug Supply

Biogen, USA

Edny Inui

Director of Business Development

Caribou Biosciences

Jian Irish

Global Head of Manufacturing

Kite Pharma, USA

Stuart Jacobson

ARMI Tissue Foundry Project Manager

DEKA, USA

Amritha Jaishankar

Associate Director

MD Stem Cell Research Fund, USA

Sunghoon Jung

Senior Director of Bioprocess R&D

PBS Biotech, Inc., USA

Ohad Karnieli, Ph.D., MBA

CEO

Atvio Biotech

Karen Katz

Director

MIT FoCUS Project, USA

Eric Kelsic

Co-Founder & CEO

Dyno Therapeutics, USA

David Kim

Director, Supply Chain

Kite, A Gilead Company, USA

Dylan Knutson

HTS Engineer, Biomedical

Recursion Pharmaceuticals, USA

Timothy Korwan

Director, New Product Development

Avantor, USA

Marcos Langtry

Head of Allogeneic Cell Therapy

Lonza, Spain

Michael Leek

Chief Executive

TC BioPharm

Graham Lilley

Process Development Engineer

Caribou Biosciences, Inc., USA

Janet Lynch Lambert

Chief Executive Officer

Alliance for Regenerative Medicine, USA

Jørgen Magnus

Head of Bio-Process Technology

Bayer, AG, Germany

Jamie Margolis

Director, Cell and Gene Therapy Operations

Be The Match BioTherapies, USA

Omar Matalka

Associate Scientist II

Biogen, USA

Ruth McDermott

Platform Manager, Regenerative Medicine

Sartorius Stedim Biotech, UK

Ginette Michaud

Director, Office of Biological Products Operations

FDA, USA

Amanda Micklus, MSc

Senior Consultant

Informa

Jeffrey Miller

Professor of Medicine, Deputy Director, Masonic Cancer Center, Division of Hematology, Oncology and Transplantation, University of Minnesota

Roger L. and Lynn C. Headrick Family Chair in Cancer Therapeutics, USA

James Miskin

Chief Technical Officer

Oxford Biomedica, UK

Ali Mohamed

VP, CMC

Immatics, USA

Shashi Murthy, PhD

Professor of Chemical Engineering

Northeastern University

Knut Niss

Chief Technology Officer

Mustang Bio, USA

Steve Oh

Director Stem Cell Bioprocessing & Institute Professor,

A*Star, Singapore

Bilal Omer

Assistant Professor

Baylor College of Medicine, USA

Anna Outhwaite

Head of ATTC Network Coordination

Cell and Gene Therapy Catapult, UK

Matthew Paquette

Operational Excellence Manager, Microbial Solutions

Charles River, USA

Toby Peach

Theatre Maker, Writer & Director

Toby Peach, UK

Joe Petrosky

VP of Global Sales

PBS Biotech, Inc., USA

Chad Presher

Associate Director, Clinical Drug Supply

Biogen, USA

Gabriele Proetzel

Director, External Neuroscience Innovation

Takeda, USA

Casey Quinn

Health Economics and Finance Research Advisor

FoCUS Project Health Technology & Policy Evaluation, LLC, USA

Jake R Boy

Application Scientist

Scientific Bioprocessing, USA

Lior Raviv

Vice President

Pluristem Therapeutics Inc.

Mark Redfern

Project Manager

Intertek, UK

Krzysztof Regulski

Head of CMC Project Management

GenSight Biologics, France

Jon A. Rowley, Ph.D.

Founder & Chief Product Officer

RoosterBio Inc.

Brandy Sargent

Editor

Cell Culture Dish, USA

Franz Schnetzinger

Director Analytical Development

Gyroscrope, UK

Donald Singer

GSK Senior Fellow, Microbiology, Biopharmaceutical GMP Operations

GSK, USA

David Smith

Chief Commercial Officer

Healios

Devyn Smith

Chief Strategy Officer and Head of Operations

Sigilon Therapeutics, USA

Sarah Snykers

QC Manager

Celyad, Belgium

Cristina Stoyanov

CMC Lead

Orchard Therapeutics, USA

Suparna Taneja-Bageshwar

Principal Scientist and Group Leader Virology and Analytical Methods Development

FUJIFILM Diosynth Biotechnologies, USA

Austin Thiel

Senior Principal Scientist

Semma Therapeutics, USA

Nick Timmins, PhD

VP, Process Development

Bluerock Therapeutics

Wouter Van t’Hof

Cord Blood Bank Director

Cleveland Cord Blood Centre, USA

Luk H. Vandenberghe

Director, Grousbeck Gene Therapy Center, Mass Eye and Ear and Harvard Co-Founder, Akouos, Gensight, and Odylia Therapeutics

Massachusetts Eye and Ear

Craig Vermeyen

Senior Manager, Packaging Engineering

Kite, a Gilead Company, USA

Loic Vincent

Head Oncology & Immunology Research Partnerships, Head of Cell Therapy Discovery

Takeda, USA

James Dean Vogel

Founder and Director

The BioProcess Institute

Xiuyan Wang

Assistant Director

Memorial Sloan Kettering Cancer Center, USA

Tariq Warsi, Ph.D.

Senior Scientist, Process Development

Amgen

Norihiro Watanabe

Instructor

Center for Cell and Gene Therapy, Baylor College of Medicine, USA

Xiaoxi Wei

Founder & CEO

X-Therma Inc., USA

Dan Wilkinson

Computational Biologist

BlueRock Therapeutics, USA

Erik Woods

Co-Founder and Chief Science Officer

Ossium Health, Inc., USA

Carolyn Yeago

Associate Director of Research

Marcus Center for Therapeutic Cell Characterization and Manufacturing, Georgia Institute of Technology, USA

Sanjin Zvonić

VP Process Science and Manufacturing

WindMIL Therapeutics, USA

Øystein Åmellem

Director, Cell Biology, Cell Culture and Cell Therapy

Thermo Fisher Scientific